fenofibrate has been researched along with sodium glutamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Liu, HY; Wang, LL; Zhang, LH; Zhou, XB | 1 |
| Huan, Y; Li, LY; Liu, Q; Liu, SN; Shen, ZF; Sun, SJ | 1 |
2 other study(ies) available for fenofibrate and sodium glutamate
| Article | Year |
|---|---|
Combination of fenofibrate and rosiglitazone synergistically ameliorate dyslipidemia and insulin resistance in mice with MSG metabolic syndrome.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue, White; Animals; Animals, Newborn; Blood Glucose; Body Weight; Drug Synergism; Eating; Fenofibrate; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Lipids; Lipoprotein Lipase; Liver; Metabolic Syndrome; Mice; Mice, Inbred ICR; RNA, Messenger; Rosiglitazone; Sodium Glutamate; Thiazolidinediones | 2010 |
Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?
Topics: Adenosine Triphosphatases; Animals; Blood Glucose; Dyslipidemias; Fenofibrate; Glucose; Homeostasis; Insulin; Insulin Secretion; Malondialdehyde; Mitochondria; NF-kappa B; Nitric Oxide Synthase Type II; Obesity; Pancreas; Protein Transport; Rats; Rats, Wistar; Sodium Glutamate; Time Factors; Up-Regulation | 2011 |